INSUBCONTINENT EXCLUSIVE:
NEW DELHI: The government might select enabling Serum Institute of Indias (SII) Covovax as a heterologous booster dosage, indicating it can
be utilized for people who have actually taken either Covishield or Covaxin for main vaccination versus Covid-19
Sources stated a conference of the subject specialist committee is set up on Wednesday to ponder on the issue
The conference is to decide on giving market authorisation to SIIs Covid-19 vaccine Covovax as a heterologous booster dosage for adults who
have been administered two doses of Covishield or Covaxin.Prakash Kumar Singh, director of federal government and regulatory affairs at the
Serum Institute of India (SII), had actually written a letter to the Drugs Controller General of India (DCGI) just recently for the approval
to Covovax as a heterologous booster dosage for adults in view of the escalating pandemic circumstance in some countries, sources said.
